Blood Neurotrophic Factors in Adults
Withdrawn before enrolling · Not applicable
Conditions studied: Healthy
In brief
The overall goal of this study is to evaluate the impact of cognitive training on blood levels of neurotrophic factors in adults.
Key facts
- Study ID
- NCT00505349
- Run by
- Posit Science Corporation
- People needed
- 0
- Starts
- 2007-06-01
- Expected to finish
- 2009-06-01
- Last updated by the study team
- 2016-02-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Phase 1: Closed
- Age 18-30 at the time of consent
- Good general medical health
- Willing to undergo venipuncture procedure
- Phase 2: Activation Pending
- Age 65 or older at the time of consent
- Mini-Mental Status Examination (MMSE) score of 26 or higher
- Willing to undergo venipuncture procedure
- Fluency in the English language
- Participant is willing and able to commit to the time requirement of the study
You may not qualify if…
- Phase 1
- Participant is experiencing chronic or acute illness
- Current substance abuse, including alcoholism
- Diagnosis of a major psychological disorder
- Current use, or use within the past 3 months of medications specified by protocol
- Participant is unwilling or unable to perform questionnaires as specified in the protocol
- Participant is not capable of giving informed consent or is unable to comprehend and/or follow directions in English
- Participant is enrolled in a concurrent clinical study that could affect the outcome of this study
- Female only: Participant is pregnant
- Phase 2
- Sensory/Motor Exclusions:
- Reported or observed difficulties with a participant's dominant hand
- Psychiatric Exclusions:
- Current diagnosis of a major psychological disorder or a psychiatric hospitalization
- Current substance abuse, including alcoholism
- Neurological Exclusions:
- Current diagnosis of a major neurological disorder that may impact cognitive functioning
- History of stroke, traumatic brain injury (leading to loss of consciousness), brain cancer, or invasive neurological procedure within the past year
- Diagnosis of medically uncontrolled seizure disorder
- Medication Exclusions:
- Current use, or use within the past 3 months of medications specified within the investigational plan
- Additional Exclusions:
- Participant is unwilling or unable to perform assessments and/or evaluations as specified in the protocol
- Participant is not capable of giving informed consent or is unable to comprehend and/or follow directions
- Participant is enrolled in a concurrent clinical study that could affect the outcome of this study
Where it is running
- Posit Science Corporation — San Francisco, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.